0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......


Basic View | Expanded View
 Showing 1-20 of 57 Articles
Viewpoint 
Joshua Bamberger, MD, MPH

This Viewpoint examines how loosening federal restrictions on the use of Medicaid funds for housing could benefit the health and quality of life for the homeleless population while also reducing medical costs.

Teachable Moment 
Justin C. Laracy, MD; Ricky Regalbuto, MD; Brian L. Block, MD

This Teachable Moment examines the potential risks associated with prostate biopsy procedures.

Original Investigation 
Morton Leibowitz, MD; Tomas Karpati, MD; Chandra J. Cohen-Stavi, MPA; Becca S. Feldman, ScD; Moshe Hoshen, PhD; Haim Bitterman, MD; Samy Suissa, PhD; Ran D. Balicer, MD, PhD
Includes: Supplemental Content

Importance  International guidelines recommend treatment with statins for patients with preexisting ischemic heart disease to prevent additional cardiovascular events but differ regarding target levels of low-density lipoprotein cholesterol (LDL-C). Trial data on this question are inconclusive and observational data are lacking.

Objective  To assess the relationship ...

Editor's Note: Low-Density Lipoprotein Cholesterol Levels and Statin Treatment; Simon B. Ascher, MD, MPH; Blake R. Charlton, MD; Rita F. Redberg, MD, MSc
Original Investigation  FREE
Colette DeJong, BA; Thomas Aguilar, MS; Chien-Wen Tseng, MD, MPH; Grace A. Lin, MD, MAS; W. John Boscardin, PhD; R. Adams Dudley, MD, MBA
Includes: Supplemental Content

Importance  The association between industry payments to physicians and prescribing rates of the brand-name medications that are being promoted is controversial. In the United States, industry payment data and Medicare prescribing records recently became publicly available.

Objective  To study the association between physicians’ receipt of industry-sponsored ...

Original Investigation 
Carrie H. Colla, PhD; Valerie A. Lewis, PhD; Lee-Sien Kao, BA; A. James O’Malley, PhD; Chiang-Hua Chang, PhD, MS; Elliott S. Fisher, MD, MPH
Includes: Supplemental Content

Importance  Accountable care contracts hold physician groups financially responsible for the quality and cost of health care delivered to patients. Focusing on clinically vulnerable patients, those with serious conditions who are responsible for the greatest proportion of spending, may result in the largest effects on both patient ...

Invited Commentary 
Kanako Y. McKee, MD; Eric Widera, MD

Constipation is a common and distressing symptom among those who are ill. In addition to adequate fluid intake and mobilization, the mainstay of constipation treatment has traditionally been the “bowel regimen,” a stimulant laxative such as sennosides combined with the stool softener docusate. Years ago, as trainees fatigued ...

Editor's Note 
Simon B. Ascher, MD, MPH; Blake R. Charlton, MD; Rita F. Redberg, MD, MSc

Statins are a staple of secondary prevention for individuals with stable cardiovascular disease. However, there is controversy on how to determine the right statin dose, and whether it should be based on low-density lipoprotein cholesterol (LDL-C) levels. Guidelines for secondary prevention in individuals with stable cardiovascular disease differ ...

Editor's Note  FREE
Robert Steinbrook, MD

Under the Open Payments program (the Physician Payment Sunshine Act, which is part of the Affordable Care Act), the Centers for Medicare & Medicaid Services has published nearly 16 million financial transactions from health care industries to physicians and teaching hospitals for August 2013 through December 2014. The ...

Review 
Samia Mora, MD, MHS; JoAnn E. Manson, MD, DrPH

Importance  Clinical decision making regarding the appropriate use of aspirin for the primary prevention of atherosclerotic cardiovascular disease (ASCVD) events is complex, and requires an individualized benefit to risk assessment.

Objective  To review advances in the individualized assessment for ASCVD and bleeding risk, and to provide ...

Evidence to Practice 
Mary Ann Lumsden, MD, MB, BS, BSc, FRCOG; Melanie Davies, MB, BS, MA, MRCP, FRCOG; Grammati Sarri, PhD; for the Guideline Development Group for Menopause: Diagnosis and Management (NICE Clinical Guideline No 23)

This Evidence to Practice report highlights the menopause guidelines recently published by the National Institute of Health and Care Excellence and suggests directions for full implementation.

Research Letter 
Todd C. Lee, MD, MPH; Emily G. McDonald, MD, MSc; Andre Bonnici, BPharm, MSc; Robyn Tamblyn, PhD

Using data from a single Canadian health center, this study examines the annual costs of prescribing laxatives in medical and surgical units.

Invited Commentary: Habitual Prescribing of Laxatives; Kanako Y. McKee, MD; Eric Widera, MD

My grandfather died of colorectal cancer when my mother was 13 years old, a catastrophic event that tore his family apart.1 When I was a child and even a young adult, his death seemed to me more an abstraction than a tragedy that unfolded slowly, devastating people ...

This editorial discusses the US Preventive Services Task Force Recommendation on Colorectal Cancer Screening.

Viewpoint 
Alex John London, PhD; Jonathan Kimmelman, PhD

This Viewpoint argues that the acceleration of the drug approval process could unequally distribute the costs and burdens of testing to vulnerable patient populations.

Perspective 
Paul Rousseau, MD
Invited Commentary: Partial Codes—A Symptom of a Larger Problem; Josué A. Zapata, MD; Eric Widera, MD
Teachable Moment 
Sarah J. Burns, DO, MS; Jonathan D. Orner; Mary E. Lacy, MD

This Teachable Moment explores whether carotid duplex ultrasonography for possible syncope should be used as part of a preopeartive workup.

Original Investigation 
Krishna K. Patel, MD; Laura Young, MD; Erik H. Howell, MD; Bo Hu, PhD; Gregory Rutecki, MD; George Thomas, MD; Michael B. Rothberg, MD, MPH
Includes: Supplemental Content

Importance  The prevalence and short-term outcomes of hypertensive urgency (systolic blood pressure ≥180 mm Hg and/or diastolic blood pressure ≥110 mm Hg) are unknown. Guidelines recommend achieving blood pressure control within 24 to 48 hours. However, some patients are referred to the emergency department (ED) or directly ...

Invited Commentary: Hypertensive Urgency—Is This a Useful Diagnosis?; Iona Heath, MB, BChir, FRCGP, FRCP
Original Investigation 
Charles C. Engel, MD; Lisa H. Jaycox, PhD; Michael C. Freed, PhD; Robert M. Bray, PhD; Donald Brambilla, PhD; Douglas Zatzick, MD; Brett Litz, PhD; Terri Tanielian, MA; Laura A. Novak, BS; Marian E. Lane, PhD; Bradley E. Belsher, PhD; Kristine L. Rae Olmsted, MSPH; Daniel P. Evatt, PhD; Russ Vandermaas-Peeler, MS; Jürgen Unützer, MD; Wayne J. Katon, MD†
Includes: Supplemental Content

Importance  It is often difficult for members of the US military to access high-quality care for posttraumatic stress disorder (PTSD) and depression.

Objective  To determine effectiveness of a centrally assisted collaborative telecare (CACT) intervention for PTSD and depression in military primary care.

Design, Setting, and Participants...

Invited Commentary: Extending Collaborative Care for Posttraumatic Mental Health; Paula P. Schnurr, PhD
Original Investigation 
Anupam B. Jena, MD, PhD; Dana Goldman, PhD; Pinar Karaca-Mandic, PhD
Includes: Supplemental Content

Importance  Use of opioids during and shortly after an acute hospitalization is warranted in some clinical settings. However, given the potential of opioids for short-term adverse events and long-term physiologic tolerance, it is important to understand the frequency of opioid prescribing at hospital discharge, hospital variation, and ...

Invited Commentary 
Iona Heath, MB, BChir, FRCGP, FRCP

In this issue of JAMA Internal Medicine, Patel et al1 interrogate the entity known as hypertensive urgency by studying patients who presented within the Cleveland Clinic system with severe hypertension but no symptoms. We are not told why these patients sought medical attention. The authors’ very ...

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts